A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability.
Identifieur interne : 000C22 ( PubMed/Curation ); précédent : 000C21; suivant : 000C23A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability.
Auteurs : Anne-Pierre Morel [France] ; Christophe Ginestier [France] ; Roxane M. Pommier [France] ; Olivier Cabaud [France] ; Emmanuelle Ruiz [France] ; Julien Wicinski [France] ; Mojgan Devouassoux-Shisheboran [France] ; Valérie Combaret [France] ; Pascal Finetti [France] ; Christelle Chassot [France] ; Christiane Pinatel [France] ; Frédérique Fauvet [France] ; Pierre Saintigny [France] ; Emilie Thomas [France] ; Caroline Moyret-Lalle [France] ; Joël Lachuer [France] ; Emmanuelle Despras [France] ; Jean-Luc Jauffret [France] ; François Bertucci [France] ; Jérôme Guitton [France] ; Anne Wierinckx [France] ; Qing Wang [France] ; Nina Radosevic-Robin [France] ; Frédérique Penault-Llorca [France] ; David G. Cox [France] ; Frédéric Hollande [Australie] ; Stéphane Ansieau [France] ; Julie Caramel [France] ; Daniel Birnbaum [France] ; Arnaud M. Vigneron [France] ; Agnès Tissier [France] ; Emmanuelle Charafe-Jauffret [France] ; Alain Puisieux [France]Source :
- Nature medicine [ 1546-170X ] ; 2017.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Altération de l'ADN, Analyse de profil d'expression de gènes, Analyse de séquence d'ADN, Analyse sur puce à tissus, Animaux, Carcinomes (génétique), Carcinomes (métabolisme), Cellules souches (cytologie), Cellules souches (métabolisme), Cellules épithéliales (cytologie), Cellules épithéliales (métabolisme), Cytométrie en flux, Différenciation cellulaire (génétique), Espèces réactives de l'oxygène, Facteur de transcription Zeb1 (génétique), Facteur de transcription Zeb1 (métabolisme), Femelle, Glandes mammaires humaines (cytologie), Humains, Immunoprécipitation de la chromatine, Immunotransfert, Instabilité du génome (génétique), Jeune adulte, Lignée cellulaire tumorale, Methionine Sulfoxide Reductases (génétique), Methionine Sulfoxide Reductases (métabolisme), Protéine p53 suppresseur de tumeur (génétique), Protéine p53 suppresseur de tumeur (métabolisme), Réaction de polymérisation en chaine en temps réel, Régulation de l'expression des gènes tumoraux, Souris de lignée NOD, Sujet âgé, Sujet âgé de 80 ans ou plus, Technique d'immunofluorescence, Transformation cellulaire néoplasique (génétique), Tumeurs du sein (génétique), Tumeurs du sein (métabolisme).
- MESH :
- cytologie : Cellules souches, Cellules épithéliales, Glandes mammaires humaines.
- génétique : Carcinomes, Différenciation cellulaire, Facteur de transcription Zeb1, Instabilité du génome, Methionine Sulfoxide Reductases, Protéine p53 suppresseur de tumeur, Transformation cellulaire néoplasique, Tumeurs du sein.
- métabolisme : Carcinomes, Cellules souches, Cellules épithéliales, Facteur de transcription Zeb1, Methionine Sulfoxide Reductases, Protéine p53 suppresseur de tumeur, Tumeurs du sein.
- Adolescent, Adulte, Adulte d'âge moyen, Altération de l'ADN, Analyse de profil d'expression de gènes, Analyse de séquence d'ADN, Analyse sur puce à tissus, Animaux, Cytométrie en flux, Espèces réactives de l'oxygène, Femelle, Humains, Immunoprécipitation de la chromatine, Immunotransfert, Jeune adulte, Lignée cellulaire tumorale, Réaction de polymérisation en chaine en temps réel, Régulation de l'expression des gènes tumoraux, Souris de lignée NOD, Sujet âgé, Sujet âgé de 80 ans ou plus, Technique d'immunofluorescence.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Aged, 80 and over, Animals, Breast Neoplasms (genetics), Breast Neoplasms (metabolism), Carcinoma (genetics), Carcinoma (metabolism), Cell Differentiation (genetics), Cell Line, Tumor, Cell Transformation, Neoplastic (genetics), Chromatin Immunoprecipitation, DNA Damage, Epithelial Cells (cytology), Epithelial Cells (metabolism), Female, Flow Cytometry, Fluorescent Antibody Technique, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Genomic Instability (genetics), Humans, Immunoblotting, Mammary Glands, Human (cytology), Methionine Sulfoxide Reductases (genetics), Methionine Sulfoxide Reductases (metabolism), Mice, Inbred NOD, Middle Aged, Reactive Oxygen Species, Real-Time Polymerase Chain Reaction, Sequence Analysis, DNA, Stem Cells (cytology), Stem Cells (metabolism), Tissue Array Analysis, Tumor Suppressor Protein p53 (genetics), Tumor Suppressor Protein p53 (metabolism), Young Adult, Zinc Finger E-box-Binding Homeobox 1 (genetics), Zinc Finger E-box-Binding Homeobox 1 (metabolism).
- MESH :
- chemical , genetics : Methionine Sulfoxide Reductases, Tumor Suppressor Protein p53, Zinc Finger E-box-Binding Homeobox 1.
- cytology : Epithelial Cells, Mammary Glands, Human, Stem Cells.
- genetics : Breast Neoplasms, Carcinoma, Cell Differentiation, Cell Transformation, Neoplastic, Genomic Instability.
- metabolism : Breast Neoplasms, Carcinoma, Epithelial Cells, Methionine Sulfoxide Reductases, Stem Cells, Tumor Suppressor Protein p53, Zinc Finger E-box-Binding Homeobox 1.
- Adolescent, Adult, Aged, Aged, 80 and over, Animals, Cell Line, Tumor, Chromatin Immunoprecipitation, DNA Damage, Female, Flow Cytometry, Fluorescent Antibody Technique, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Humans, Immunoblotting, Mice, Inbred NOD, Middle Aged, Reactive Oxygen Species, Real-Time Polymerase Chain Reaction, Sequence Analysis, DNA, Tissue Array Analysis, Young Adult.
Abstract
Chromosomal instability (CIN), a feature of most adult neoplasms from their early stages onward, is a driver of tumorigenesis. However, several malignancy subtypes, including some triple-negative breast cancers, display a paucity of genomic aberrations, thus suggesting that tumor development may occur in the absence of CIN. Here we show that the differentiation status of normal human mammary epithelial cells dictates cell behavior after an oncogenic event and predetermines the genetic routes toward malignancy. Whereas oncogene induction in differentiated cells induces massive DNA damage, mammary stem cells are resistant, owing to a preemptive program driven by the transcription factor ZEB1 and the methionine sulfoxide reductase MSRB3. The prevention of oncogene-induced DNA damage precludes induction of the oncosuppressive p53-dependent DNA-damage response, thereby increasing stem cells' intrinsic susceptibility to malignant transformation. In accord with this model, a subclass of breast neoplasms exhibit unique pathological features, including high ZEB1 expression, a low frequency of TP53 mutations and low CIN.
DOI: 10.1038/nm.4323
PubMed: 28394329
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000C25
Links to Exploration step
pubmed:28394329Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability.</title>
<author><name sortKey="Morel, Anne Pierre" sort="Morel, Anne Pierre" uniqKey="Morel A" first="Anne-Pierre" last="Morel">Anne-Pierre Morel</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ginestier, Christophe" sort="Ginestier, Christophe" uniqKey="Ginestier C" first="Christophe" last="Ginestier">Christophe Ginestier</name>
<affiliation wicri:level="1"><nlm:affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Pommier, Roxane M" sort="Pommier, Roxane M" uniqKey="Pommier R" first="Roxane M" last="Pommier">Roxane M. Pommier</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cabaud, Olivier" sort="Cabaud, Olivier" uniqKey="Cabaud O" first="Olivier" last="Cabaud">Olivier Cabaud</name>
<affiliation wicri:level="1"><nlm:affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ruiz, Emmanuelle" sort="Ruiz, Emmanuelle" uniqKey="Ruiz E" first="Emmanuelle" last="Ruiz">Emmanuelle Ruiz</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wicinski, Julien" sort="Wicinski, Julien" uniqKey="Wicinski J" first="Julien" last="Wicinski">Julien Wicinski</name>
<affiliation wicri:level="1"><nlm:affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Devouassoux Shisheboran, Mojgan" sort="Devouassoux Shisheboran, Mojgan" uniqKey="Devouassoux Shisheboran M" first="Mojgan" last="Devouassoux-Shisheboran">Mojgan Devouassoux-Shisheboran</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Combaret, Valerie" sort="Combaret, Valerie" uniqKey="Combaret V" first="Valérie" last="Combaret">Valérie Combaret</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre Léon Bérard, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre Léon Bérard, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Finetti, Pascal" sort="Finetti, Pascal" uniqKey="Finetti P" first="Pascal" last="Finetti">Pascal Finetti</name>
<affiliation wicri:level="1"><nlm:affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Chassot, Christelle" sort="Chassot, Christelle" uniqKey="Chassot C" first="Christelle" last="Chassot">Christelle Chassot</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Pinatel, Christiane" sort="Pinatel, Christiane" uniqKey="Pinatel C" first="Christiane" last="Pinatel">Christiane Pinatel</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fauvet, Frederique" sort="Fauvet, Frederique" uniqKey="Fauvet F" first="Frédérique" last="Fauvet">Frédérique Fauvet</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Saintigny, Pierre" sort="Saintigny, Pierre" uniqKey="Saintigny P" first="Pierre" last="Saintigny">Pierre Saintigny</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Thomas, Emilie" sort="Thomas, Emilie" uniqKey="Thomas E" first="Emilie" last="Thomas">Emilie Thomas</name>
<affiliation wicri:level="1"><nlm:affiliation>Fondation Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Fondation Synergie Lyon Cancer, Centre Léon Bérard, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Moyret Lalle, Caroline" sort="Moyret Lalle, Caroline" uniqKey="Moyret Lalle C" first="Caroline" last="Moyret-Lalle">Caroline Moyret-Lalle</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lachuer, Joel" sort="Lachuer, Joel" uniqKey="Lachuer J" first="Joël" last="Lachuer">Joël Lachuer</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Despras, Emmanuelle" sort="Despras, Emmanuelle" uniqKey="Despras E" first="Emmanuelle" last="Despras">Emmanuelle Despras</name>
<affiliation wicri:level="1"><nlm:affiliation>Université Paris-Sud, CNRS-UMR 8200, Unit of Genetic Stability and Oncogenesis, Equipe Labellisée Ligue contre le Cancer, Institut de Cancérologie Gustave Roussy, Villejuif, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris-Sud, CNRS-UMR 8200, Unit of Genetic Stability and Oncogenesis, Equipe Labellisée Ligue contre le Cancer, Institut de Cancérologie Gustave Roussy, Villejuif</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Jauffret, Jean Luc" sort="Jauffret, Jean Luc" uniqKey="Jauffret J" first="Jean-Luc" last="Jauffret">Jean-Luc Jauffret</name>
<affiliation wicri:level="1"><nlm:affiliation>Clinique Phenicia, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Clinique Phenicia, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bertucci, Francois" sort="Bertucci, Francois" uniqKey="Bertucci F" first="François" last="Bertucci">François Bertucci</name>
<affiliation wicri:level="1"><nlm:affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Guitton, Jerome" sort="Guitton, Jerome" uniqKey="Guitton J" first="Jérôme" last="Guitton">Jérôme Guitton</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre Bénite, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre Bénite</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wierinckx, Anne" sort="Wierinckx, Anne" uniqKey="Wierinckx A" first="Anne" last="Wierinckx">Anne Wierinckx</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wang, Qing" sort="Wang, Qing" uniqKey="Wang Q" first="Qing" last="Wang">Qing Wang</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre Léon Bérard, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre Léon Bérard, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Radosevic Robin, Nina" sort="Radosevic Robin, Nina" uniqKey="Radosevic Robin N" first="Nina" last="Radosevic-Robin">Nina Radosevic-Robin</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, Jean Perrin Cancer Center and ERTICa Research Group, University of Auvergne, Clermont-Ferrand, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Pathology, Jean Perrin Cancer Center and ERTICa Research Group, University of Auvergne, Clermont-Ferrand</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Penault Llorca, Frederique" sort="Penault Llorca, Frederique" uniqKey="Penault Llorca F" first="Frédérique" last="Penault-Llorca">Frédérique Penault-Llorca</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, Jean Perrin Cancer Center and ERTICa Research Group, University of Auvergne, Clermont-Ferrand, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Pathology, Jean Perrin Cancer Center and ERTICa Research Group, University of Auvergne, Clermont-Ferrand</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cox, David G" sort="Cox, David G" uniqKey="Cox D" first="David G" last="Cox">David G. Cox</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hollande, Frederic" sort="Hollande, Frederic" uniqKey="Hollande F" first="Frédéric" last="Hollande">Frédéric Hollande</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Pathology, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ansieau, Stephane" sort="Ansieau, Stephane" uniqKey="Ansieau S" first="Stéphane" last="Ansieau">Stéphane Ansieau</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Caramel, Julie" sort="Caramel, Julie" uniqKey="Caramel J" first="Julie" last="Caramel">Julie Caramel</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Birnbaum, Daniel" sort="Birnbaum, Daniel" uniqKey="Birnbaum D" first="Daniel" last="Birnbaum">Daniel Birnbaum</name>
<affiliation wicri:level="1"><nlm:affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Vigneron, Arnaud M" sort="Vigneron, Arnaud M" uniqKey="Vigneron A" first="Arnaud M" last="Vigneron">Arnaud M. Vigneron</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tissier, Agnes" sort="Tissier, Agnes" uniqKey="Tissier A" first="Agnès" last="Tissier">Agnès Tissier</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Charafe Jauffret, Emmanuelle" sort="Charafe Jauffret, Emmanuelle" uniqKey="Charafe Jauffret E" first="Emmanuelle" last="Charafe-Jauffret">Emmanuelle Charafe-Jauffret</name>
<affiliation wicri:level="1"><nlm:affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Puisieux, Alain" sort="Puisieux, Alain" uniqKey="Puisieux A" first="Alain" last="Puisieux">Alain Puisieux</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28394329</idno>
<idno type="pmid">28394329</idno>
<idno type="doi">10.1038/nm.4323</idno>
<idno type="wicri:Area/PubMed/Corpus">000C25</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000C25</idno>
<idno type="wicri:Area/PubMed/Curation">000C22</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000C22</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability.</title>
<author><name sortKey="Morel, Anne Pierre" sort="Morel, Anne Pierre" uniqKey="Morel A" first="Anne-Pierre" last="Morel">Anne-Pierre Morel</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ginestier, Christophe" sort="Ginestier, Christophe" uniqKey="Ginestier C" first="Christophe" last="Ginestier">Christophe Ginestier</name>
<affiliation wicri:level="1"><nlm:affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Pommier, Roxane M" sort="Pommier, Roxane M" uniqKey="Pommier R" first="Roxane M" last="Pommier">Roxane M. Pommier</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cabaud, Olivier" sort="Cabaud, Olivier" uniqKey="Cabaud O" first="Olivier" last="Cabaud">Olivier Cabaud</name>
<affiliation wicri:level="1"><nlm:affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ruiz, Emmanuelle" sort="Ruiz, Emmanuelle" uniqKey="Ruiz E" first="Emmanuelle" last="Ruiz">Emmanuelle Ruiz</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wicinski, Julien" sort="Wicinski, Julien" uniqKey="Wicinski J" first="Julien" last="Wicinski">Julien Wicinski</name>
<affiliation wicri:level="1"><nlm:affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Devouassoux Shisheboran, Mojgan" sort="Devouassoux Shisheboran, Mojgan" uniqKey="Devouassoux Shisheboran M" first="Mojgan" last="Devouassoux-Shisheboran">Mojgan Devouassoux-Shisheboran</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Combaret, Valerie" sort="Combaret, Valerie" uniqKey="Combaret V" first="Valérie" last="Combaret">Valérie Combaret</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre Léon Bérard, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre Léon Bérard, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Finetti, Pascal" sort="Finetti, Pascal" uniqKey="Finetti P" first="Pascal" last="Finetti">Pascal Finetti</name>
<affiliation wicri:level="1"><nlm:affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Chassot, Christelle" sort="Chassot, Christelle" uniqKey="Chassot C" first="Christelle" last="Chassot">Christelle Chassot</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Pinatel, Christiane" sort="Pinatel, Christiane" uniqKey="Pinatel C" first="Christiane" last="Pinatel">Christiane Pinatel</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fauvet, Frederique" sort="Fauvet, Frederique" uniqKey="Fauvet F" first="Frédérique" last="Fauvet">Frédérique Fauvet</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Saintigny, Pierre" sort="Saintigny, Pierre" uniqKey="Saintigny P" first="Pierre" last="Saintigny">Pierre Saintigny</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Thomas, Emilie" sort="Thomas, Emilie" uniqKey="Thomas E" first="Emilie" last="Thomas">Emilie Thomas</name>
<affiliation wicri:level="1"><nlm:affiliation>Fondation Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Fondation Synergie Lyon Cancer, Centre Léon Bérard, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Moyret Lalle, Caroline" sort="Moyret Lalle, Caroline" uniqKey="Moyret Lalle C" first="Caroline" last="Moyret-Lalle">Caroline Moyret-Lalle</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lachuer, Joel" sort="Lachuer, Joel" uniqKey="Lachuer J" first="Joël" last="Lachuer">Joël Lachuer</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Despras, Emmanuelle" sort="Despras, Emmanuelle" uniqKey="Despras E" first="Emmanuelle" last="Despras">Emmanuelle Despras</name>
<affiliation wicri:level="1"><nlm:affiliation>Université Paris-Sud, CNRS-UMR 8200, Unit of Genetic Stability and Oncogenesis, Equipe Labellisée Ligue contre le Cancer, Institut de Cancérologie Gustave Roussy, Villejuif, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris-Sud, CNRS-UMR 8200, Unit of Genetic Stability and Oncogenesis, Equipe Labellisée Ligue contre le Cancer, Institut de Cancérologie Gustave Roussy, Villejuif</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Jauffret, Jean Luc" sort="Jauffret, Jean Luc" uniqKey="Jauffret J" first="Jean-Luc" last="Jauffret">Jean-Luc Jauffret</name>
<affiliation wicri:level="1"><nlm:affiliation>Clinique Phenicia, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Clinique Phenicia, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bertucci, Francois" sort="Bertucci, Francois" uniqKey="Bertucci F" first="François" last="Bertucci">François Bertucci</name>
<affiliation wicri:level="1"><nlm:affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Guitton, Jerome" sort="Guitton, Jerome" uniqKey="Guitton J" first="Jérôme" last="Guitton">Jérôme Guitton</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre Bénite, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre Bénite</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wierinckx, Anne" sort="Wierinckx, Anne" uniqKey="Wierinckx A" first="Anne" last="Wierinckx">Anne Wierinckx</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wang, Qing" sort="Wang, Qing" uniqKey="Wang Q" first="Qing" last="Wang">Qing Wang</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre Léon Bérard, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre Léon Bérard, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Radosevic Robin, Nina" sort="Radosevic Robin, Nina" uniqKey="Radosevic Robin N" first="Nina" last="Radosevic-Robin">Nina Radosevic-Robin</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, Jean Perrin Cancer Center and ERTICa Research Group, University of Auvergne, Clermont-Ferrand, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Pathology, Jean Perrin Cancer Center and ERTICa Research Group, University of Auvergne, Clermont-Ferrand</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Penault Llorca, Frederique" sort="Penault Llorca, Frederique" uniqKey="Penault Llorca F" first="Frédérique" last="Penault-Llorca">Frédérique Penault-Llorca</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, Jean Perrin Cancer Center and ERTICa Research Group, University of Auvergne, Clermont-Ferrand, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Pathology, Jean Perrin Cancer Center and ERTICa Research Group, University of Auvergne, Clermont-Ferrand</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cox, David G" sort="Cox, David G" uniqKey="Cox D" first="David G" last="Cox">David G. Cox</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hollande, Frederic" sort="Hollande, Frederic" uniqKey="Hollande F" first="Frédéric" last="Hollande">Frédéric Hollande</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Pathology, University of Melbourne, Parkville, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ansieau, Stephane" sort="Ansieau, Stephane" uniqKey="Ansieau S" first="Stéphane" last="Ansieau">Stéphane Ansieau</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Caramel, Julie" sort="Caramel, Julie" uniqKey="Caramel J" first="Julie" last="Caramel">Julie Caramel</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Birnbaum, Daniel" sort="Birnbaum, Daniel" uniqKey="Birnbaum D" first="Daniel" last="Birnbaum">Daniel Birnbaum</name>
<affiliation wicri:level="1"><nlm:affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Vigneron, Arnaud M" sort="Vigneron, Arnaud M" uniqKey="Vigneron A" first="Arnaud M" last="Vigneron">Arnaud M. Vigneron</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tissier, Agnes" sort="Tissier, Agnes" uniqKey="Tissier A" first="Agnès" last="Tissier">Agnès Tissier</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Charafe Jauffret, Emmanuelle" sort="Charafe Jauffret, Emmanuelle" uniqKey="Charafe Jauffret E" first="Emmanuelle" last="Charafe-Jauffret">Emmanuelle Charafe-Jauffret</name>
<affiliation wicri:level="1"><nlm:affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Puisieux, Alain" sort="Puisieux, Alain" uniqKey="Puisieux A" first="Alain" last="Puisieux">Alain Puisieux</name>
<affiliation wicri:level="1"><nlm:affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Nature medicine</title>
<idno type="eISSN">1546-170X</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Animals</term>
<term>Breast Neoplasms (genetics)</term>
<term>Breast Neoplasms (metabolism)</term>
<term>Carcinoma (genetics)</term>
<term>Carcinoma (metabolism)</term>
<term>Cell Differentiation (genetics)</term>
<term>Cell Line, Tumor</term>
<term>Cell Transformation, Neoplastic (genetics)</term>
<term>Chromatin Immunoprecipitation</term>
<term>DNA Damage</term>
<term>Epithelial Cells (cytology)</term>
<term>Epithelial Cells (metabolism)</term>
<term>Female</term>
<term>Flow Cytometry</term>
<term>Fluorescent Antibody Technique</term>
<term>Gene Expression Profiling</term>
<term>Gene Expression Regulation, Neoplastic</term>
<term>Genomic Instability (genetics)</term>
<term>Humans</term>
<term>Immunoblotting</term>
<term>Mammary Glands, Human (cytology)</term>
<term>Methionine Sulfoxide Reductases (genetics)</term>
<term>Methionine Sulfoxide Reductases (metabolism)</term>
<term>Mice, Inbred NOD</term>
<term>Middle Aged</term>
<term>Reactive Oxygen Species</term>
<term>Real-Time Polymerase Chain Reaction</term>
<term>Sequence Analysis, DNA</term>
<term>Stem Cells (cytology)</term>
<term>Stem Cells (metabolism)</term>
<term>Tissue Array Analysis</term>
<term>Tumor Suppressor Protein p53 (genetics)</term>
<term>Tumor Suppressor Protein p53 (metabolism)</term>
<term>Young Adult</term>
<term>Zinc Finger E-box-Binding Homeobox 1 (genetics)</term>
<term>Zinc Finger E-box-Binding Homeobox 1 (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Altération de l'ADN</term>
<term>Analyse de profil d'expression de gènes</term>
<term>Analyse de séquence d'ADN</term>
<term>Analyse sur puce à tissus</term>
<term>Animaux</term>
<term>Carcinomes (génétique)</term>
<term>Carcinomes (métabolisme)</term>
<term>Cellules souches (cytologie)</term>
<term>Cellules souches (métabolisme)</term>
<term>Cellules épithéliales (cytologie)</term>
<term>Cellules épithéliales (métabolisme)</term>
<term>Cytométrie en flux</term>
<term>Différenciation cellulaire (génétique)</term>
<term>Espèces réactives de l'oxygène</term>
<term>Facteur de transcription Zeb1 (génétique)</term>
<term>Facteur de transcription Zeb1 (métabolisme)</term>
<term>Femelle</term>
<term>Glandes mammaires humaines (cytologie)</term>
<term>Humains</term>
<term>Immunoprécipitation de la chromatine</term>
<term>Immunotransfert</term>
<term>Instabilité du génome (génétique)</term>
<term>Jeune adulte</term>
<term>Lignée cellulaire tumorale</term>
<term>Methionine Sulfoxide Reductases (génétique)</term>
<term>Methionine Sulfoxide Reductases (métabolisme)</term>
<term>Protéine p53 suppresseur de tumeur (génétique)</term>
<term>Protéine p53 suppresseur de tumeur (métabolisme)</term>
<term>Réaction de polymérisation en chaine en temps réel</term>
<term>Régulation de l'expression des gènes tumoraux</term>
<term>Souris de lignée NOD</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Technique d'immunofluorescence</term>
<term>Transformation cellulaire néoplasique (génétique)</term>
<term>Tumeurs du sein (génétique)</term>
<term>Tumeurs du sein (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Methionine Sulfoxide Reductases</term>
<term>Tumor Suppressor Protein p53</term>
<term>Zinc Finger E-box-Binding Homeobox 1</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr"><term>Cellules souches</term>
<term>Cellules épithéliales</term>
<term>Glandes mammaires humaines</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en"><term>Epithelial Cells</term>
<term>Mammary Glands, Human</term>
<term>Stem Cells</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Breast Neoplasms</term>
<term>Carcinoma</term>
<term>Cell Differentiation</term>
<term>Cell Transformation, Neoplastic</term>
<term>Genomic Instability</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Carcinomes</term>
<term>Différenciation cellulaire</term>
<term>Facteur de transcription Zeb1</term>
<term>Instabilité du génome</term>
<term>Methionine Sulfoxide Reductases</term>
<term>Protéine p53 suppresseur de tumeur</term>
<term>Transformation cellulaire néoplasique</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Breast Neoplasms</term>
<term>Carcinoma</term>
<term>Epithelial Cells</term>
<term>Methionine Sulfoxide Reductases</term>
<term>Stem Cells</term>
<term>Tumor Suppressor Protein p53</term>
<term>Zinc Finger E-box-Binding Homeobox 1</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Carcinomes</term>
<term>Cellules souches</term>
<term>Cellules épithéliales</term>
<term>Facteur de transcription Zeb1</term>
<term>Methionine Sulfoxide Reductases</term>
<term>Protéine p53 suppresseur de tumeur</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Animals</term>
<term>Cell Line, Tumor</term>
<term>Chromatin Immunoprecipitation</term>
<term>DNA Damage</term>
<term>Female</term>
<term>Flow Cytometry</term>
<term>Fluorescent Antibody Technique</term>
<term>Gene Expression Profiling</term>
<term>Gene Expression Regulation, Neoplastic</term>
<term>Humans</term>
<term>Immunoblotting</term>
<term>Mice, Inbred NOD</term>
<term>Middle Aged</term>
<term>Reactive Oxygen Species</term>
<term>Real-Time Polymerase Chain Reaction</term>
<term>Sequence Analysis, DNA</term>
<term>Tissue Array Analysis</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Altération de l'ADN</term>
<term>Analyse de profil d'expression de gènes</term>
<term>Analyse de séquence d'ADN</term>
<term>Analyse sur puce à tissus</term>
<term>Animaux</term>
<term>Cytométrie en flux</term>
<term>Espèces réactives de l'oxygène</term>
<term>Femelle</term>
<term>Humains</term>
<term>Immunoprécipitation de la chromatine</term>
<term>Immunotransfert</term>
<term>Jeune adulte</term>
<term>Lignée cellulaire tumorale</term>
<term>Réaction de polymérisation en chaine en temps réel</term>
<term>Régulation de l'expression des gènes tumoraux</term>
<term>Souris de lignée NOD</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Technique d'immunofluorescence</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Chromosomal instability (CIN), a feature of most adult neoplasms from their early stages onward, is a driver of tumorigenesis. However, several malignancy subtypes, including some triple-negative breast cancers, display a paucity of genomic aberrations, thus suggesting that tumor development may occur in the absence of CIN. Here we show that the differentiation status of normal human mammary epithelial cells dictates cell behavior after an oncogenic event and predetermines the genetic routes toward malignancy. Whereas oncogene induction in differentiated cells induces massive DNA damage, mammary stem cells are resistant, owing to a preemptive program driven by the transcription factor ZEB1 and the methionine sulfoxide reductase MSRB3. The prevention of oncogene-induced DNA damage precludes induction of the oncosuppressive p53-dependent DNA-damage response, thereby increasing stem cells' intrinsic susceptibility to malignant transformation. In accord with this model, a subclass of breast neoplasms exhibit unique pathological features, including high ZEB1 expression, a low frequency of TP53 mutations and low CIN.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28394329</PMID>
<DateCreated><Year>2017</Year>
<Month>04</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>08</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>08</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-170X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>23</Volume>
<Issue>5</Issue>
<PubDate><Year>2017</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Nature medicine</Title>
<ISOAbbreviation>Nat. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability.</ArticleTitle>
<Pagination><MedlinePgn>568-578</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/nm.4323</ELocationID>
<Abstract><AbstractText>Chromosomal instability (CIN), a feature of most adult neoplasms from their early stages onward, is a driver of tumorigenesis. However, several malignancy subtypes, including some triple-negative breast cancers, display a paucity of genomic aberrations, thus suggesting that tumor development may occur in the absence of CIN. Here we show that the differentiation status of normal human mammary epithelial cells dictates cell behavior after an oncogenic event and predetermines the genetic routes toward malignancy. Whereas oncogene induction in differentiated cells induces massive DNA damage, mammary stem cells are resistant, owing to a preemptive program driven by the transcription factor ZEB1 and the methionine sulfoxide reductase MSRB3. The prevention of oncogene-induced DNA damage precludes induction of the oncosuppressive p53-dependent DNA-damage response, thereby increasing stem cells' intrinsic susceptibility to malignant transformation. In accord with this model, a subclass of breast neoplasms exhibit unique pathological features, including high ZEB1 expression, a low frequency of TP53 mutations and low CIN.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morel</LastName>
<ForeName>Anne-Pierre</ForeName>
<Initials>AP</Initials>
<AffiliationInfo><Affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>LabEx DEVweCAN, Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ginestier</LastName>
<ForeName>Christophe</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pommier</LastName>
<ForeName>Roxane M</ForeName>
<Initials>RM</Initials>
<AffiliationInfo><Affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>LabEx DEVweCAN, Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cabaud</LastName>
<ForeName>Olivier</ForeName>
<Initials>O</Initials>
<AffiliationInfo><Affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ruiz</LastName>
<ForeName>Emmanuelle</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>LabEx DEVweCAN, Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wicinski</LastName>
<ForeName>Julien</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Devouassoux-Shisheboran</LastName>
<ForeName>Mojgan</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>LabEx DEVweCAN, Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Combaret</LastName>
<ForeName>Valérie</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Centre Léon Bérard, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Finetti</LastName>
<ForeName>Pascal</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chassot</LastName>
<ForeName>Christelle</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>LabEx DEVweCAN, Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pinatel</LastName>
<ForeName>Christiane</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>LabEx DEVweCAN, Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Fauvet</LastName>
<ForeName>Frédérique</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>LabEx DEVweCAN, Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Saintigny</LastName>
<ForeName>Pierre</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>LabEx DEVweCAN, Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Thomas</LastName>
<ForeName>Emilie</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Fondation Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Moyret-Lalle</LastName>
<ForeName>Caroline</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>LabEx DEVweCAN, Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lachuer</LastName>
<ForeName>Joël</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>LabEx DEVweCAN, Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>ProfileXpert, Bron, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Despras</LastName>
<ForeName>Emmanuelle</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Université Paris-Sud, CNRS-UMR 8200, Unit of Genetic Stability and Oncogenesis, Equipe Labellisée Ligue contre le Cancer, Institut de Cancérologie Gustave Roussy, Villejuif, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jauffret</LastName>
<ForeName>Jean-Luc</ForeName>
<Initials>JL</Initials>
<AffiliationInfo><Affiliation>Clinique Phenicia, Marseille, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bertucci</LastName>
<ForeName>François</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Guitton</LastName>
<ForeName>Jérôme</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Université de Lyon, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre Bénite, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wierinckx</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>LabEx DEVweCAN, Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>ProfileXpert, Bron, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Qing</ForeName>
<Initials>Q</Initials>
<AffiliationInfo><Affiliation>Centre Léon Bérard, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Radosevic-Robin</LastName>
<ForeName>Nina</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Department of Pathology, Jean Perrin Cancer Center and ERTICa Research Group, University of Auvergne, Clermont-Ferrand, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Penault-Llorca</LastName>
<ForeName>Frédérique</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Department of Pathology, Jean Perrin Cancer Center and ERTICa Research Group, University of Auvergne, Clermont-Ferrand, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cox</LastName>
<ForeName>David G</ForeName>
<Initials>DG</Initials>
<AffiliationInfo><Affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>LabEx DEVweCAN, Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hollande</LastName>
<ForeName>Frédéric</ForeName>
<Initials>F</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-7046-8392</Identifier>
<AffiliationInfo><Affiliation>Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ansieau</LastName>
<ForeName>Stéphane</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>LabEx DEVweCAN, Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Caramel</LastName>
<ForeName>Julie</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>LabEx DEVweCAN, Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Birnbaum</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vigneron</LastName>
<ForeName>Arnaud M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo><Affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>LabEx DEVweCAN, Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tissier</LastName>
<ForeName>Agnès</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>LabEx DEVweCAN, Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Charafe-Jauffret</LastName>
<ForeName>Emmanuelle</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe labellisée Ligue Contre le Cancer, Marseille, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Puisieux</LastName>
<ForeName>Alain</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>LabEx DEVweCAN, Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2017</Year>
<Month>04</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Nat Med</MedlineTA>
<NlmUniqueID>9502015</NlmUniqueID>
<ISSNLinking>1078-8956</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C495901">TP53 protein, human</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016159">Tumor Suppressor Protein p53</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C486307">ZEB1 protein, human</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000071799">Zinc Finger E-box-Binding Homeobox 1</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 1.8.4.-</RegistryNumber>
<NameOfSubstance UI="D051150">Methionine Sulfoxide Reductases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 1.8.4.12</RegistryNumber>
<NameOfSubstance UI="C524352">MSRB3 protein, human</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002277" MajorTopicYN="N">Carcinoma</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002471" MajorTopicYN="N">Cell Transformation, Neoplastic</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D047369" MajorTopicYN="N">Chromatin Immunoprecipitation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005455" MajorTopicYN="N">Fluorescent Antibody Technique</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015972" MajorTopicYN="Y">Gene Expression Regulation, Neoplastic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D042822" MajorTopicYN="N">Genomic Instability</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015151" MajorTopicYN="N">Immunoblotting</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D042361" MajorTopicYN="N">Mammary Glands, Human</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051150" MajorTopicYN="N">Methionine Sulfoxide Reductases</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016688" MajorTopicYN="N">Mice, Inbred NOD</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D046888" MajorTopicYN="N">Tissue Array Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016159" MajorTopicYN="N">Tumor Suppressor Protein p53</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000071799" MajorTopicYN="N">Zinc Finger E-box-Binding Homeobox 1</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>07</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2017</Year>
<Month>03</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>4</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>8</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>4</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28394329</ArticleId>
<ArticleId IdType="pii">nm.4323</ArticleId>
<ArticleId IdType="doi">10.1038/nm.4323</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C22 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000C22 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:28394329 |texte= A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:28394329" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |